SureTrader
Home > Boards > US Listed > Miscellaneous > Rigel Pharmaceuticals Inc. (RIGL)

7:40AM On The Wires (WIRES) :

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 420
Posts 22,038
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 8/3/2016 5:29:05 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/2/2016 4:19:05 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/2/2016 4:18:38 PM
Rigel Announces Second Quarter 2016 Financial Results and Provides Portfolio Update "PR Newswire (US)" - 8/2/2016 4:10:00 PM
Rigel Announces Conference Call and Webcast to Report Second Quarter 2016 Financial Results "PR Newswire (US)" - 7/26/2016 7:30:00 AM
Rigel to Present at Jefferies 2016 Healthcare Conference "PR Newswire (US)" - 6/2/2016 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2016 7:04:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2016 7:01:24 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2016 6:55:50 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2016 6:52:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2016 6:44:57 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/12/2016 6:40:15 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/12/2016 4:22:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/9/2016 6:39:30 PM
Rigel to Present at Upcoming American Association of Immunologists (AAI) Annual Meeting "PR Newswire (US)" - 5/5/2016 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/3/2016 5:32:18 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/3/2016 4:28:30 PM
Rigel Announces First Quarter 2016 Financial Results "PR Newswire (US)" - 5/3/2016 4:05:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 5/3/2016 6:15:16 AM
Rigel Announces Conference Call and Webcast to Report First Quarter 2016 Financial Results "PR Newswire (US)" - 4/26/2016 7:30:00 AM
Rigel Announces Presentations at Upcoming American Association of Cancer Research (AACR) Conference "PR Newswire (US)" - 4/12/2016 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/6/2016 6:25:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/6/2016 6:24:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/6/2016 6:20:20 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/6/2016 6:16:47 PM
surf1944   Friday, 05/06/11 09:58:11 AM
Re: surf1944 post# 130
Post # of 338 
7:40AM On The Wires (WIRES) :

Rigel Pharmaceuticals, Inc. (RIGL) announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer (PFE) is returning full rights to the R343 program as a result of its decision to exit the allergy and respiratory therapeutic area within R&D. Rigel is evaluating the details of R343's development to date and expects to design a Phase 2 clinical trial with R343 later this year.


surf's up......crikey



SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist